Prof. Ningli Wang has engaged in clinical and scientific research in ophthalmology for 34 years, and performed more than 20,000 surgeries. He currently serves as a consultant expert in Central Health Care Committee. The main areas of his works are: the pathogenesis and diagnosis and treatment of glaucoma.
He is the Director of Beijing Tongren Eye Center (Key Discipline of the Ministry of Education and Clinical Key Specialty of National Health and Family Planning Commission), and Director of the National Research Center for Clinical Diagnosis and Treatment Engineering Technology. He served as primary investigator (PI) of 11 major projects, including National High-tech R&D Program (863 Program), Key Program of National Natural Science Foundation of China (NSFC), NSFC Projects of International Cooperation and Exchange, Major Project of the Ministry of Science and Technology of China. Besides that, he has led 2 national major blindness prevention projects. Prof. Wang has by now served as supervisor for 10 postdoctoral students and 52 doctoral students.
He has published 429 peer-review papers as the first author or corresponding author, including 167 SCI articles, with 5388 citations in total and 4765 citations by others. Among his publications, 25 papers are published on articles (first author or corresponding author) the top two international ophthalmology journals; 4 papers are published on Nature Genetics and 1 paper on Nature Communication. In terms of the number of articles published in the glaucoma field, he ranks the first in China and top 10 worldwide. He is the chief-editor of 26 textbooks and monographs on ophthalmology and 12 standard specifications, and has been authorized 20 patents. As PI, he was awarded 2 National Science and Technology Progress Second Class Awards and 4 Provincial Science and Technology Progress First Class Awards.